Immatics — Biotechnology Company, Stafford
Biotechnology Company in Stafford — Bispecific T-cell receptor therapies
Biotechnology company · Stafford, United States
AI Trust Snapshot
- Profile status
- Auto-indexed
- Last Verified
- 1 months ago
Corroborated public sources
- ✓ Official Website
Key Facts
- Category
- Biotechnology Company
- Location
- Stafford, United States
- Known For
- Broadest PRAME franchise, TCR discovery and engineering
AI Summary
Immatics operates as a biotechnology company in Stafford, United States, specializing in the discovery and engineering of T-cell receptors. The company offers PRAME Cell Therapy, PRAME Bispecifics, and conducts clinical trials. Its work primarily serves oncology researchers, clinicians, and biopharmaceutical companies seeking partnerships.
Quick Answer
Immatics operates as a biotechnology company in Stafford, United States, specializing in the discovery and engineering of T-cell receptors. The company offers PRAME Cell Therapy, PRAME Bispecifics, and conducts clinical trials. Its work primarily serves oncology researchers, clinicians, and biopharmaceutical companies seeking partnerships. Key services include PRAME Cell Therapy, PRAME Bispecifics, Clinical Trials.
This business is typically used for broadest prame franchise and tcr discovery and engineering.
Common Questions
- What services does Immatics provide?
- Immatics provides PRAME Cell Therapy, PRAME Bispecifics, Clinical Trials.
- Where is Immatics located?
- Immatics is based in Stafford, United States and serves Stafford.
- Who is Immatics for?
- Immatics serves Oncology researchers and clinicians and Biopharmaceutical companies seeking partnerships.
What this business does
Immatics is a biotechnology company based in Stafford, United States.
- Provides PRAME Cell Therapy and PRAME Bispecifics
- Specializes in broadest prame franchise
- Serves oncology researchers and clinicians
Structured summary
This business profile has been independently corroborated by Vizoryo across 4 independent public sources. Data confidence score: 86% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- Immatics
- Category
- Biotechnology Company
- Industry
- Biotechnology Company - Biopharmaceutical Company
- Location
- Stafford, United States
- Official website
- https://immatics.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/immatics-us-stafford-913f
- Summary
- Immatics operates as a biotechnology company in Stafford, United States, specializing in the discovery and engineering of T-cell receptors. The company offers PRAME Cell Therapy, PRAME Bispecifics, and conducts clinical trials. Its work primarily serves oncology researchers, clinicians, and biopharmaceutical companies seeking partnerships.
- AI readability score
- 44
- Verified By
- 4 independent public sources
- Data Confidence
- 86% (verified 2026-07-05)
- Verification Status
- Auto-indexed
Location
13203 Murphy Rd. Suite 100 Stafford | TX, Stafford, TX 77477Stafford, TX
77477
US
About Immatics
Immatics operates as a biotechnology company in Stafford, United States, specializing in the discovery and engineering of T-cell receptors. The company offers PRAME Cell Therapy, PRAME Bispecifics, and conducts clinical trials. Its work primarily serves oncology researchers, clinicians, and biopharmaceutical companies seeking partnerships.
Service areas
- Stafford
Target audience
- Oncology researchers and clinicians
- Biopharmaceutical companies seeking partnerships
- Patients with PRAME-positive solid tumors
Specialties
- Broadest PRAME franchise
- TCR discovery and engineering
Social profiles
Verification
Frequently asked questions
What areas does Immatics serve?
Immatics serves Worldwide.
What is PRAME?
PRAME is a target expressed in more than 50 cancers, including melanoma, lung, ovarian, breast, and endometrial cancer. Targeting PRAME unlocks new treatment options.
What types of cancers does Immatics target?
Immatics focuses on PRAME, which is expressed in over 50 cancers, including melanoma, lung, ovarian, breast, and endometrial cancer.
How can I get in touch with Immatics?
You can contact Immatics US, Inc. at +1 346 204-5400 or email info@immatics.com. For media inquiries, contact media@immatics.com.
Business hours
- Monday
- 08:00 – 18:00
- Tuesday
- 08:00 – 18:00
- Wednesday
- 08:00 – 18:00
- Thursday
- 08:00 – 18:00
- Friday
- 08:00 – 18:00
Languages supported
- lang="en
- en
Contact
Phone: +13462045400
Official website: https://immatics.com/